Treatments for unresectable hepatocellular carcinoma: insights from CheckMate 9DW – Authors' reply
We thank Akhil Santhosh and Nihanthy D Sreenath and Liting Zhang and colleagues for their interest in our trial. The CheckMate 9DW trial showed clinically significant overall survival benefit for ...
Immune-based therapies are transforming advanced liver cancer care, resulting in curative options previously considered ...
Pivotal Phase III liver cancer study enrolling in Europe and IsraelRAMAT GAN, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) -- ...
Liver cancer is often diagnosed at an advanced stage, when tumors are too large for a transplant or removal. Immunotherapy, ...
A new Cedars-Sinai Cancer study shows that patients with advanced liver cancer who receive immunotherapy to shrink their ...
WASHINGTON -- Liver cancer risk after hepatitis C virus (HCV) cure was significantly greater in patients with metabolic ...
New online map lets readers explore cancer risks in their counties…older, poor-quality housing leaves residents vulnerable to ...
Sportschosun on MSN
Measuring the degree of liver cancer immune cell exhaustion and predicting the effectiveness of immu...
Professor Jang Jung-won of the Department of Gastroenterology at Seoul St. Mary's Hospital of Catholic University and ...
As Liver Cancer Awareness Month ends, Drs. Vogel and Yarchoan highlight the urgent need for greater awareness, support and ...
This fact sheet explains lung cancer staging, and provides lung cancer survival rates by stage, type, and age. Our easy-to-read fact sheets provide clinicians with reliable information to share with ...
A new study has found that while comorbid conditions are often factored into cancer prognoses, it is older age, rather than overall comorbidity burden, that is most strongly linked to poorer survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback